194 related articles for article (PubMed ID: 88369)
1. Relative effectiveness of spinal cord and purified myelin basic protein in producing resistance to experimental allergic encephalomyelitis.
McDermott JR; Keith AB
Eur Neurol; 1979; 18(2):136-9. PubMed ID: 88369
[TBL] [Abstract][Full Text] [Related]
2. Suppression of chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs by administration of liposome-associated myelin basic protein.
Strejan GH; Gilbert JJ; St Louis J
J Neuroimmunol; 1984 Nov; 7(1):27-41. PubMed ID: 6209299
[TBL] [Abstract][Full Text] [Related]
3. Prevention of experimental allergic encephalomyelitis by ganglioside GM4.
Mullin BR; Patrick DH; Poore CM; Smith MT
Brain Res; 1984 Mar; 296(1):174-6. PubMed ID: 6201236
[TBL] [Abstract][Full Text] [Related]
4. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein.
Popovich PG; Yu JY; Whitacre CC
J Neuropathol Exp Neurol; 1997 Dec; 56(12):1323-38. PubMed ID: 9413281
[TBL] [Abstract][Full Text] [Related]
5. Relapsing experimental allergic encephalomyelitis induced with isolated myelin and with myelin basic protein plus myelin lipids.
Madrid RE; Wiśniewski HM; Iqbal K; Pullarkat RK; Lassmann H
J Neurol Sci; 1981 Jun; 50(3):399-411. PubMed ID: 6167679
[TBL] [Abstract][Full Text] [Related]
6. Epicutaneous immunization with myelin basic protein protects from the experimental autoimmune encephalomyelitis.
Majewska M; Zajac K; Srebro Z; Sura P; Ksiazek L; Zemelka M; Szczepanik M
Pharmacol Rep; 2007; 59(1):74-9. PubMed ID: 17377209
[TBL] [Abstract][Full Text] [Related]
7. Induction of resistance to experimental allergic encephalomyelitis in newborn guinea pigs.
Staykova M; Kozovska M; Kirazjan N; Goranov I
Neurol Psychiatr (Bucur); 1989; 27(3):225-9. PubMed ID: 2479972
[TBL] [Abstract][Full Text] [Related]
8. Chronic relapsing experimental autoimmune encephalomyelitis. treatment with combinations of myelin components promotes clinical and structural recovery.
Traugott U; Stone SH; Raine CS
J Neurol Sci; 1982 Oct; 56(1):65-73. PubMed ID: 6183403
[TBL] [Abstract][Full Text] [Related]
9. Chronic progressive experimental allergic encephalomyelitis (EAE) in adult guinea pigs.
Wisniewski HM; Madrid RE
J Neuropathol Exp Neurol; 1983 May; 42(3):243-55. PubMed ID: 6188808
[TBL] [Abstract][Full Text] [Related]
10. Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form.
Massacesi L; Vergelli M; Zehetbauer B; Liuzzi GM; Olivotto J; Ballerini C; Uccelli A; Mancardi L; Riccio P; Amaducci L
J Neurol Sci; 1993 Oct; 119(1):91-8. PubMed ID: 7504090
[TBL] [Abstract][Full Text] [Related]
11. Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85.
Tselios T; Daliani I; Deraos S; Thymianou S; Matsoukas E; Troganis A; Gerothanassis I; Mouzaki A; Mavromoustakos T; Probert L; Matsoukas J
Bioorg Med Chem Lett; 2000 Dec; 10(24):2713-7. PubMed ID: 11133075
[TBL] [Abstract][Full Text] [Related]
12. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.
Sun JB; Rask C; Olsson T; Holmgren J; Czerkinsky C
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7196-201. PubMed ID: 8692968
[TBL] [Abstract][Full Text] [Related]
13. Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide.
Hoffman PM; Gaston DD; Spitler LE
Clin Immunol Immunopathol; 1973 Apr; 1(3):364-71. PubMed ID: 4127172
[No Abstract] [Full Text] [Related]
14. Suppression of experimental allergic encephalomyelitis in guinea/pigs by liposome-associated human myelin basic protein.
Strejan GH; Percy DH; St Louis J; Surlan D; Paty DW
J Immunol; 1981 Nov; 127(5):2064-9. PubMed ID: 6170686
[TBL] [Abstract][Full Text] [Related]
15. Induction of experimental autoimmune encephalomyelitis in guinea pigs using myelin basic protein and myelin glycolipids.
Kusunoki S; Yu RK; Kim JH
J Neuroimmunol; 1988 Jul; 18(4):303-14. PubMed ID: 2454944
[TBL] [Abstract][Full Text] [Related]
16. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
Ramírez F; Mason D
Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
[TBL] [Abstract][Full Text] [Related]
17. [Immunomorphological characteristics of experimental allergic encephalomyelitis induced by an encephalitogenic polypeptide].
Zhitnukhin IuL; Khizhniak MG
Biull Eksp Biol Med; 1987 Mar; 103(3):343-6. PubMed ID: 2435338
[TBL] [Abstract][Full Text] [Related]
18. Experimental allergic encephalomyelitis (EAE) in mice. I. Induction of EAE with mouse spinal cord homogenate and myelin basic protein.
Yasuda T; Tsumita T; Nagai Y; Mitsuzawa E; Ohtani S
Jpn J Exp Med; 1975 Oct; 45(5):423-7. PubMed ID: 57253
[TBL] [Abstract][Full Text] [Related]
19. Durability of immune protection against experimental autoimmune encephalomyelitis.
Bernard CC; Mackay IR; Whittingham S; Brous P
Cell Immunol; 1976 Mar; 22(2):297-310. PubMed ID: 58731
[No Abstract] [Full Text] [Related]
20. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids.
Moore GR; Traugott U; Farooq M; Norton WT; Raine CS
Lab Invest; 1984 Oct; 51(4):416-24. PubMed ID: 6207382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
